CLINICAL_TRIALS
trial_result
· 2021-02-10
Clinical Trial Update: A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity [Phase 2]
Summary
Phase 2 randomized, double-blind trial of fenretinide in subjects with obesity is suspended; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Obesity, Insulin Resistance | Phase 2 | Status: SUSPENDED | Results posted: 2021-02-10